| Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. MH Le, P Devaki, NB Ha, DW Jun, HS Te, RC Cheung, MH Nguyen Plos One 12, 2017 | 311 | 2017 |
| Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005–2010 I Ditah, P Devaki, HN Luma, C Ditah, B Njei, C Jaiyeoba, A Salami, ... Clinical Gastroenterology and Hepatology 12 (4), 636-643. e2, 2014 | 236 | 2014 |
| The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010 I Ditah, F Ditah, P Devaki, O Ewelukwa, C Ditah, B Njei, HN Luma, ... Journal of hepatology 60 (4), 691-698, 2014 | 199 | 2014 |
| Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey I Ditah, F Ditah, P Devaki, C Ditah, PS Kamath, M Charlton Hepatology 60 (3), 815-822, 2014 | 112 | 2014 |
| Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry RJ Wong, P Devaki, L Nguyen, R Cheung, MH Nguyen Liver transplantation 20 (5), 528-535, 2014 | 61 | 2014 |
| Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification. N Aggarwal, R Lopez, S Gabbard, N Wadhwa, P Devaki, PN Thota Diseases of the Esophagus 30 (12), 2017 | 45 | 2017 |
| Approximately one‐half of patients with early‐stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post‐MELD … P Devaki, RJ Wong, V Marupakula, S Nangia, L Nguyen, IC Ditah, ... Cancer 120 (11), 1725-1732, 2014 | 31 | 2014 |
| Exercise-induced proteinuria? F Saeed, PN Pavan Kumar Devaki, L Mahendrakar, JL Holley Journal of Family Practice 61 (1), 23, 2012 | 31 | 2012 |
| Increased long-term survival among patients with hepatocellular carcinoma after implementation of model for end-stage liver disease score RJ Wong, P Devaki, L Nguyen, R Cheung, C Cho–Phan, MH Nguyen Clinical Gastroenterology and Hepatology 12 (9), 1534-1540. e1, 2014 | 23 | 2014 |
| Meta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirin NH Nguyen, SA McCormack, P Vutien, BE Yee, P Devaki, D Jencks, ... Intervirology 58 (1), 27-34, 2015 | 12 | 2015 |
| Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of … P Devaki, D Jencks, BE Yee, MH Nguyen Hepatology international 9, 431-437, 2015 | 8 | 2015 |
| Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks NH Nguyen, SA McCormack, BE Yee, P Devaki, D Jencks, DT Chao, ... Hepatology international 8, 540-549, 2014 | 7 | 2014 |
| Association between Aspirin and Statin Use and the Prevalence of Non-alcoholic Fatty Liver Disease: A Cross Sectional Study from National Health and Nutrition Examination … P Devaki, A McCullough Gastroenterology 152 (5), S1202-S1203, 2017 | 3 | 2017 |
| Su1074 Meta-Analysis: Sustained Virologic Response (SVR) in Patients With Infection With Hepatitis C Virus Genotype 5 (HCV-5) Versus Genotype 1 (HCV-1) and HCV Genotype 2/3 … P Devaki, DS Jencks, S Nangia, V Marupakula, MH Nguyen Gastroenterology 5 (146), S-981-S-982, 2014 | 2 | 2014 |
| Su1073 Sustained Virological Response (SVR) to Standard Interferon (IFN) or Pegylated Interferon (PEG IFN) and Ribavirin (RBV) in Patients With Hepatitis C Virus Genotype 5 … P Devaki, DS Jencks, V Marupakula, S Nangia, MH Nguyen Gastroenterology 5 (146), S-981, 2014 | 2 | 2014 |
| Epidemiology of Fecal Incontinence in US Adults from 2005 to 2010: Prevalence, Trends, and Risk Factors IC Ditah, P Devaki, B Njei, CO Jaiyeoba, CM Ditah, O Ewelukwa, ... Gastroenterology 1, S363, 2013 | 2 | 2013 |
| Suboptimal Vaccination Rates for Hepatitis B Virus (HBV) among US Adults at High Risk for HBV Infection in National Health and Nutrition Examination Survey (NHANES) from 2001 … P Devaki, R Wong, LH Nguyen, S Nangia, S Sinha, V Marupakula, ... Hepatology 58, 611A-612A, 2013 | 1 | 2013 |
| Changes in Hepatitis B (HBV) Vaccination Rates and Differences in Various General Demographics across National Health and Nutrition Examination Surveys (NHANES) from 1999–2010: 844 P Devaki, LH Nguyen, R Wong, S Sinha, V Marupakula, S Nangia, ... Hepatology 58, 607A-608A, 2013 | 1 | 2013 |
| Fecal Incontinence in US Adults from 2005 to 2010: Epidemiology and Risk Factors Presidential Poster: 1762 I Ditah, P Devaki, C Jaiyeoba, B Njei, C Ditah, V Marupakula, A Salami, ... Official journal of the American College of Gastroenterology| ACG 107, S717, 2012 | 1 | 2012 |
| Cost-Effectiveness of Universal Hepatitis B Vaccination in US Adults with Diabetes Mellitus: A Markov Simulation Model: 343 B Njei, I Ditah, P Devaki, JK Lim Hepatology 56, 359A, 2012 | 1 | 2012 |
